ONKURE THERAPEUTICS, INC. Operating Lease Liability
ONKURE THERAPEUTICS, INC. (OKUR) had Operating Lease Liability of $926.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-04
- 2026-06-30: Operating Lease, Liability $926.00K.
- 2026-03-31: Operating Lease, Liability $409.00K.
- 2025-12-31: Operating Lease, Liability $549.00K.
- 2025-09-30: Operating Lease, Liability $687.00K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $926.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $409.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $549.00K 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $687.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $823.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $955.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.08M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $665.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $823.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $907.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $674.00K 10-K · filed 2025-03-10 | $973.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $1.14M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.22M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.34M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.46M 10-K · filed 2023-03-27 | |
| 2022-09-30 | $1.35M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.47M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.58M 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |